The Importance of Treating OSD and Lid Margin Disease Preoperatively

• April 11, 2026

New Immune Target in Dry Eye

Investigators say rexinoid therapy may represent a new class of dry eye treatment focused on regenerative immune signaling

• June 30, 2026

• 3 min

Phacoemulsification with goniosynechialysis for nanophthalmos with secondary angle-closure or secondary angle-closure glaucoma: a 20-case series and stepwise management strategy

• by Hongyan Zhu, Zuohong Wu, Yong Wang, Xun Zhan, Jin Lv, Li Ye

• June 1, 2026

Case Report: Identification of a CRYGD variant in a family with congenital cataract

• by Junjie Deng, Jianli Ma, Yixiao Li, Wenjing Wang, Chunli Ma, Mengxue Li, Yaqin Jiang, Han Zhang

• June 10, 2026